Concentrix (NASDAQ:CNXC – Get Free Report) posted its quarterly earnings data on Tuesday. The company reported $2.95 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.93 by $0.02, Briefing.com reports. The firm had revenue of $2.55 billion for the quarter, compared to the consensus estimate of $2.54 billion. Concentrix had a net margin of 3.25% and a return on equity of 16.02%. The company’s revenue for the quarter was up 4.3% compared to the same quarter last year. During the same quarter in the prior year, the company posted $3.26 earnings per share. Concentrix updated its Q1 2026 guidance to 2.570-2.690 EPS and its FY 2026 guidance to 11.480-12.070 EPS.
Concentrix Trading Down 8.1%
Concentrix stock opened at $40.48 on Tuesday. The firm has a market cap of $2.52 billion, a PE ratio of 8.56, a P/E/G ratio of 0.59 and a beta of 0.48. Concentrix has a 12 month low of $31.63 and a 12 month high of $66.00. The stock’s 50 day simple moving average is $38.43 and its two-hundred day simple moving average is $46.77. The company has a current ratio of 1.56, a quick ratio of 1.56 and a debt-to-equity ratio of 1.10.
Insider Activity
In other news, CEO Christopher A. Caldwell bought 2,000 shares of the firm’s stock in a transaction that occurred on Thursday, October 30th. The stock was purchased at an average cost of $42.03 per share, for a total transaction of $84,060.00. Following the purchase, the chief executive officer directly owned 286,661 shares in the company, valued at approximately $12,048,361.83. This trade represents a 0.70% increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 3.20% of the stock is currently owned by corporate insiders.
Institutional Inflows and Outflows
Wall Street Analysts Forecast Growth
Several equities analysts recently issued reports on the company. Canaccord Genuity Group reissued a “buy” rating and issued a $80.00 target price on shares of Concentrix in a research report on Tuesday, September 23rd. Barrington Research reiterated an “outperform” rating and set a $62.00 price target on shares of Concentrix in a research note on Monday. Wall Street Zen raised Concentrix from a “hold” rating to a “buy” rating in a report on Saturday, October 25th. Weiss Ratings upgraded Concentrix from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Thursday. Finally, Robert W. Baird reduced their price target on shares of Concentrix from $75.00 to $62.00 and set an “outperform” rating for the company in a research report on Monday, September 29th. Three investment analysts have rated the stock with a Buy rating and two have given a Hold rating to the stock. According to MarketBeat, Concentrix has an average rating of “Moderate Buy” and an average target price of $66.25.
Get Our Latest Analysis on Concentrix
Trending Headlines about Concentrix
Here are the key news stories impacting Concentrix this week:
- Positive Sentiment: Barrington Research reaffirmed an “outperform” rating and set a $62.00 price target, signaling analyst conviction that shares have upside from current levels. Read More.
- Neutral Sentiment: Concentrix reported fiscal Q4 and full-year 2025 results; the release is driving today’s market action as investors parse revenue, margins and management commentary for forward guidance. Read More.
- Neutral Sentiment: Pre-earnings previews and valuation looks have been published, giving investors context on expectations and multiples ahead of the print; these pieces discuss whether recent share moves and valuation are warranted. Read More.
- Neutral Sentiment: Coverage pieces and earnings previews outline key items to watch (revenue growth, margin trends, contract mix and guidance), which can amplify volatility as the market digests results. Read More.
- Neutral Sentiment: Reported short-interest data in the feed is anomalous (shows zero shares), so it does not appear to be a meaningful driver of today’s move based on the available figures.
- Negative Sentiment: Analysts and articles flag concern that while Concentrix has previously beaten guidance, expected revenue growth is slowing — investors often punish stocks when earnings beats are accompanied by weaker growth outlooks. Read More.
- Negative Sentiment: Commentary questioning whether current pricing reflects Concentrix’s multi‑year share decline and changing fundamentals may reinforce selling pressure until there’s clearer guidance or an earnings rebound. Read More.
About Concentrix
Concentrix Inc (NASDAQ: CNXC) is a global business services company specializing in customer engagement solutions and technology‐driven business process outsourcing. The firm’s offerings encompass customer care delivered across voice and digital channels, back‐office processing, analytics and consulting, and automated workflow management. By integrating proprietary platforms, strategic partnerships and advanced automation, Concentrix helps clients enhance customer experiences and streamline operations.
Its capabilities extend to digital marketing and technology implementation, leveraging artificial intelligence, machine learning and data analytics to optimize customer journeys.
Read More
- Five stocks we like better than Concentrix
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- How a Family Trust May Be Able To Help Preserve Your Wealth
- A U.S. “birthright” claim worth trillions – activated quietly
- Ticker Revealed: Pre-IPO Access to “Next Elon Musk” Company
- This stock gets a 94 out of 100
Receive News & Ratings for Concentrix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Concentrix and related companies with MarketBeat.com's FREE daily email newsletter.
